Graham Walmsley's most recent trade in Akero Therapeutics Inc was a trade of 26,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Oct. 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Akero Therapeutics Inc | Graham Walmsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2025 | 26,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.02 per share. | 08 Oct 2025 | 26,000 | 28,168 (0%) | 0% | 23.0 | 598,520 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.97 per share. | 08 Oct 2025 | 23,832 | 93,000 (0%) | 0% | 20.0 | 475,925 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2025 | 23,832 | 0 | - | - | Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.13 per share. | 08 Oct 2025 | 15,000 | 43,168 (0%) | 0% | 8.1 | 121,950 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2025 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.20 per share. | 08 Oct 2025 | 13,000 | 69,168 (0%) | 0% | 25.2 | 327,600 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.32 per share. | 08 Oct 2025 | 13,000 | 56,168 (0%) | 0% | 26.3 | 342,160 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2025 | 13,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2025 | 13,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 24,150 | 24,150 | - | - | Stock Option (right to buy) | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 9,398 | 11,566 (0%) | 0% | 0 | Common Stock | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 44.75 per share. | 25 Mar 2025 | 91,309 | 1,091,309 (3%) | 0% | 44.7 | 4,085,804 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 43.01 per share. | 25 Mar 2025 | 58,691 | 1,150,000 (4%) | 0% | 43.0 | 2,524,417 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 43.55 per share. | 25 Mar 2025 | 50,000 | 1,200,000 (4%) | 0% | 43.6 | 2,177,700 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 48.00 per share. | 30 Jan 2025 | 200,000 | 1,000,000 (3%) | 0% | 48 | 9,600,000 | Common Stock |
| Olema Pharma Inc | Graham Walmsley | Director | Sale of securities on an exchange or to another person at price $ 6.75 per share. | 13 Dec 2024 | 700,761 | 0 | - | 6.8 | 4,730,137 | Common Stock |
| Olema Pharma Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 6.75 per share. | 13 Dec 2024 | 700,761 | 1,408,875 | - | 6.8 | 4,730,137 | Common Stock |
| Olema Pharma Inc | Walmsley Graham | Director | Purchase of securities on an exchange or from another person at price $ 6.75 per share. | 13 Dec 2024 | 700,761 | 700,761 | - | 6.8 | 4,730,137 | Common Stock |
| Olema Pharma Inc | Graham Walmsley | Director | Sale of securities on an exchange or to another person at price $ 6.75 per share. | 13 Dec 2024 | 700,761 | 0 | - | 6.8 | 4,730,137 | Common Stock |
| Olema Pharma Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option (right to buy) | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2024 | 26,000 | 26,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Graham Walmsley | Director | Sale of securities on an exchange or to another person at price $ 14.85 per share. | 04 Jun 2024 | 700,000 | 700,761 | - | 14.9 | 10,395,000 | Common Stock |
| Olema Pharma Inc | Graham Walmsley | Director | Sale of securities on an exchange or to another person at price $ 14.85 per share. | 04 Jun 2024 | 475,000 | 708,114 | - | 14.9 | 7,053,750 | Common Stock |
| Akero Therapeutics Inc | Walmsley Graham | Director | Purchase of securities on an exchange or from another person at price $ 19.80 per share. | 08 Dec 2023 | 50,000 | 750,000 (2%) | 0% | 19.8 | 990,240 | Common Stock |
| Akero Therapeutics Inc | Walmsley Graham | Director | Purchase of securities on an exchange or from another person at price $ 19.85 per share. | 08 Dec 2023 | 50,000 | 800,000 (2%) | 0% | 19.9 | 992,700 | Common Stock |
| Akero Therapeutics Inc | Walmsley Graham | Director | Purchase of securities on an exchange or from another person at price $ 16.99 per share. | 30 Nov 2023 | 50,000 | 700,000 (2%) | 0% | 17.0 | 849,730 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 16.90 per share. | 30 Nov 2023 | 50,000 | 650,000 (2%) | 0% | 16.9 | 844,835 | Common Stock |
| Olema Pharma Inc | Graham Walmsley | Director | Sale of securities on an exchange or to another person at price $ 14.85 per share. | 12 Sep 2023 | 700,000 | 700,761 | - | 14.9 | 10,395,000 | Common Stock |
| Olema Pharma Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 9.84 per share. | 12 Sep 2023 | 508,130 | 1,668,130 | - | 9.8 | 4,999,999 | Common Stock |
| Olema Pharma Inc | Graham Walmsley | Director | Sale of securities on an exchange or to another person at price $ 14.85 per share. | 12 Sep 2023 | 475,000 | 708,114 | - | 14.9 | 7,053,750 | Common Stock |
| Olema Pharma Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 13.08 per share. | 12 Sep 2023 | 50,000 | 1,800,000 | - | 13.1 | 654,250 | Common Stock |
| Olema Pharma Inc | Walmsley Graham | Director | Purchase of securities on an exchange or from another person at price $ 14.95 per share. | 12 Sep 2023 | 50,000 | 1,750,000 | - | 14.9 | 747,480 | Common Stock |
| Olema Pharma Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 14.73 per share. | 12 Sep 2023 | 31,870 | 1,700,000 | - | 14.7 | 469,550 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 42.06 per share. | 08 Aug 2023 | 25,000 | 600,000 (2%) | 0% | 42.1 | 1,051,475 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 42.69 per share. | 28 Jul 2023 | 30,000 | 550,000 (1%) | 0% | 42.7 | 1,280,709 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 43.26 per share. | 28 Jul 2023 | 25,000 | 575,000 (2%) | 0% | 43.3 | 1,081,525 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 26.00 per share. | 19 Sep 2022 | 400,000 | 400,000 (1%) | 1% | 26 | 10,400,000 | Common Stock |
| Akero Therapeutics Inc | Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 42.00 per share. | 19 Sep 2022 | 120,000 | 520,000 (1%) | 0% | 42 | 5,040,000 | Common Stock |
| Olema Pharma Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Alx Oncology Holdings Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 12,004 | 12,004 | - | - | Stock option (right to buy) | |
| Olema Pharma Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jun 2021 | 23,832 | 0 | - | - | Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jun 2021 | 13,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jun 2021 | 13,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) |